文献速递临床试验与 GCP

针刺治疗糖尿病周围神经病变:随机安慰针对照试验方案

Acupuncture for diabetic peripheral neuropathy: study protocol for a randomized, placebo-controlled trial.
PubMed 文献 · Trials · 2020-10-26

本研究为随机安慰针对照临床试验方案,计划招募118例糖尿病周围神经病变患者,按1:1随机分入手针组或假针组,12周内共24次治疗,第6个月随访。主要结局为第12周腓总运动神经传导速度较基线变化,同时评估多项神经传导指标、血糖、量表评分及安全性。

要点

  • 手针与假针比较,评估对糖尿病周围神经病变的疗效与安全性。
  • 主要结局为第12周腓总运动神经传导速度较基线变化。
  • 计划纳入118例,1:1随机,12周24次治疗,第6个月随访。

核心结论

  • 该试验旨在为手针治疗糖尿病周围神经病变的疗效与安全性提供高质量证据。

研究设计与样本

  • 随机、安慰对照临床试验方案,计划招募118例糖尿病周围神经病变患者,按1:1随机分入手针组或假针组。
  • 所有患者12周内接受24次治疗,第6个月到研究中心随访评估。

关键数值与推荐

  • 主要结局为第12周腓总运动神经传导速度较基线变化。
  • 次要结局包括第12周腓总运动神经动作电位波幅与潜伏期、腓肠感觉神经传导速度、波幅与潜伏期较基线变化。
  • 次要结局还包括第12周空腹血糖、餐后2小时血糖、糖化血红蛋白较基线变化。
  • 次要结局包括第12周和第6个月密歇根神经病变筛查量表评分和糖尿病特异性生活质量量表较基线变化。
  • 整个试验期间评估安全性,并由患者评估设盲有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diabetic peripheral neuropathy (DPN) is the most common chronic complication of diabetes mellitus that has a considerable impact on quality of life, but there are few effective therapeutic strategies. The aim of this trial is to determine the efficacy and safety of manual acupuncture (MA) versus sham acupuncture (SA) for DPN. METHODS/DESIGN: This is a study protocol for a randomized, placebo-controlled clinical trial. A total of 118 patients with DPN will be recruited and randomly assigned in a 1:1 ratio to either the MA group or SA group. All patients will receive 24 sessions over 12 weeks. Participants will complete the trial by visiting the research center at month 6 for a follow-up assessment. The primary outcome is peroneal motor nerve conduction velocity (peroneal MNCV) at week 12 compared with baseline. Secondary outcomes include peroneal motor nerve action potential amplitude (peroneal MNAP) and latent period (peroneal MNLP), sural sensory nerve conduction velocity (sural SNCV), action potential amplitude (sural SNAP) and latent period (sural SNLP), fasting plasma glucose (FPG), 2-h postprandial blood glucose (2hPG), glycated hemoglobin (HbAlc) at week 12 compared with baseline, Michigan Neuropathy Screening Instrument (MNSI) score and Diabetes Specific Quality of Life scale (DSQL) at week 12 and month 6 compared with baseline. Safety will be assessed during the whole trial. Masking effectiveness will be assessed by patients. DISCUSSION: This trial may provide high-quality evidence for evaluating the efficacy and safety of MA treatment for DPN compared with SA treatment. Results of this study will be published in peer-reviewed journals. TRIAL REGISTRATION: Chinese Clinical Trials Registry ChiCTR1800020444. First registered on 29 December 2018, retrospectively registered, http://www.chictr.org.cn/showproj.aspx?Proj=31063 .

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Deng H, Shu Y, Lv P, et al. Acupuncture for diabetic peripheral neuropathy: study protocol for a randomized, placebo-controlled trial. Trials. 2020. PMID: 33106185. doi:10.1186/s13063-020-04811-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。